• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Insamo Launches with $12M Funding from Playground Global, venBio, and MRL Ventures Fund to...

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Feb 21, 2024 at 11:32: AM
via Insamo, a biotechnology company pioneering the discovery of membrane-permeable and orally available cyclic-peptides, today announced $12 million in seed capital from Playground Global, venBio, and MRL Ventures Fund (MRLV). MRLV is a corporate venture arm of Merck & Co., Inc which invests in early-stage, preclinical therapeutics companies.

article source
 




Top Bottom
Back
Quote